Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

Market Cap	32.32B
Revenue (ttm)	4.61B
Net Income (ttm)	1.23B
Shares Out	921.30M
EPS (ttm)	1.34
PE Ratio	26.17
Forward PE	24.36
Dividend	0.60 (1.71%)
Ex-Dividend Date	Jun 6, 2025

Volume	5,179,256
Average Volume	5,829,190
Open	36.42
Previous Close	35.08
Day's Range	33.87 - 36.42
52-Week Range	18.41 - 47.37
Beta	0.22
RSI	33.19
Earnings Date	Oct 24, 2025

About SHE:002773

Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China. It also develops a pipeline of clinical and pre-clinical programs for ophthalmology, CNS, oncology, and common disease. Chengdu Kanghong Pharmaceuticals Group Co., Ltd. was founded in 1996 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,462
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002773

Financial Performance

In 2024, SHE:002773's revenue was 4.45 billion, an increase of 12.51% compared to the previous year's 3.96 billion. Earnings were 1.19 billion, an increase of 14.02%.